USA - NASDAQ:AIRS - US0094961002 - Common Stock
The current stock price of AIRS is 4.07 USD. In the past month the price decreased by -58.51%. In the past year, price decreased by -41.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.38 | 98.85B | ||
| CI | THE CIGNA GROUP | 9.6 | 72.77B | ||
| LH | LABCORP HOLDINGS INC | 16.42 | 21.59B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.99 | 20.72B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 104.74 | 18.92B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.92B | ||
| DVA | DAVITA INC | 12.63 | 8.33B | ||
| HIMS | HIMS & HERS HEALTH INC | 67.15 | 8.20B | ||
| CHE | CHEMED CORP | 19.79 | 6.34B | ||
| RDNT | RADNET INC | 208.32 | 6.09B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 30.93 | 5.59B | ||
| OPCH | OPTION CARE HEALTH INC | 18.98 | 4.59B |
AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. The company is headquartered in Miami Beach, Florida and currently employs 389 full-time employees. The company went IPO on 2021-10-29. The firm owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). The company operates through the direct medical procedure services segment. The firm offers fat removal procedures across treatment areas. The company also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.
AIRSCULPT TECHNOLOGIES INC
1111 Lincoln Road, Suite 802
Miami Beach FLORIDA US
CEO: Aaron Rollins
Employees: 406
Phone: 17867099690
AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. The company is headquartered in Miami Beach, Florida and currently employs 389 full-time employees. The company went IPO on 2021-10-29. The firm owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). The company operates through the direct medical procedure services segment. The firm offers fat removal procedures across treatment areas. The company also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.
The current stock price of AIRS is 4.07 USD. The price decreased by -2.4% in the last trading session.
AIRS does not pay a dividend.
AIRS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
The next ex-dividend date for AIRSCULPT TECHNOLOGIES INC (AIRS) is August 25, 2022.
AIRSCULPT TECHNOLOGIES INC (AIRS) will report earnings on 2026-03-12, after the market close.
You can find the ownership structure of AIRSCULPT TECHNOLOGIES INC (AIRS) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to AIRS. AIRS has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AIRS reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 7.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.32% | ||
| ROE | -15.92% | ||
| Debt/Equity | 0.58 |
10 analysts have analysed AIRS and the average price target is 6.12 USD. This implies a price increase of 50.37% is expected in the next year compared to the current price of 4.07.
For the next year, analysts expect an EPS growth of 86.4% and a revenue growth -11.71% for AIRS